Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Richards, R, Burls, A, Payne, N
Formato:	Journal article
Lenguaje:	English
Publicado:	2000